Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Oct;113(2):479–484. doi: 10.1111/j.1476-5381.1994.tb17014.x

Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor.

J S Lacroix 1, L G Ulman 1, E K Potter 1
PMCID: PMC1510115  PMID: 7834199

Abstract

1. In pentobarbitone anaesthetized dogs, preganglionic stimulation of the superior cervical sympathetic nerve (15V, 1 ms, 10 Hz) induced marked reduction of nasal arterial blood flow, whereas parasympathetic nerve stimulation (5 V, 1 ms, 10-30 Hz) evoked frequency-dependent vasodilatation. 2. Sympathetic nerve stimulation for 3 min at 10 Hz evoked significant (P < 0.05) and prolonged attenuation of the vasodilator response to subsequent parasympathetic stimulation. Pretreatment with phentolamine (0.5 mg kg-1 h-1), propranolol (1 mg kg-1) and atropine (0.5 mg kg-1) reduced the vasoconstrictor effect of sympathetic stimulation by 35 +/- 4% whereas the parasympathetic nerve-evoked vasodilatation was not significantly modified. Atropine-resistant parasympathetic vasodilatation remained significantly attenuated for more than 30 min after non-adrenergic sympathetic nerve-evoked vasoconstriction. 3. Vasodilator effects of exogenous vasoactive intestinal polypeptide and peptide histidine isoleucine and vasoconstrictor effects of exogenous neuropeptide Y (NPY) and the NPY analogue [Leu31, Pro34] NPY (Y1-receptor agonist, 8 nmol kg-1), were not altered by adrenoceptor antagonists and atropine f1p4eas the effects of exogenous noradrenaline and acetylcholine were virtually abolished. Attenuation of parasympathetic-evoked vasodilatation could be mimicked by exogenous NPY (8 nmol kg-1) and the NPY analogue, N-acetyl [Leu28, Leu31] NPY 24-36 (Y2-receptor agonist, 20 nmol kg-1) but not by exogenous Y1-receptor agonist. The Y2-receptor agonist did not show significant vasoconstrictor action. 4. It is concluded that sympathetic nerve stimulation attenuates parasympathetic vasodilatation via NPY release acting on prejunctional Y2 receptors.

Full text

PDF
479

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anggård A., Densert O. Adrenergic innervation of the nasal mucosa in cat. A histological and physiological study. Acta Otolaryngol. 1974 Sep-Oct;78(3-4):232–241. doi: 10.3109/00016487409126349. [DOI] [PubMed] [Google Scholar]
  2. Anggård A., Edwall L. The effects of sympathetic nerve stimulation on the tracer disappearance rate and local blood content in the nasal mucosa of the cat. Acta Otolaryngol. 1974 Jan-Feb;77(1):131–139. doi: 10.3109/00016487409124608. [DOI] [PubMed] [Google Scholar]
  3. Berridge T. L., Roach A. G. Characterization of alpha-adrenoceptors in the vasculature of the canine nasal mucosa. Br J Pharmacol. 1986 Jun;88(2):345–354. doi: 10.1111/j.1476-5381.1986.tb10210.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Eccles R. The domestic pig as an experimental animal for studies on the nasal cycle. Acta Otolaryngol. 1978 May-Jun;85(5-6):431–436. doi: 10.3109/00016487809121472. [DOI] [PubMed] [Google Scholar]
  5. Eccles R., Wilson H. The autonomic innervation of the nasal blood vessels of the cat. J Physiol. 1974 May;238(3):549–560. doi: 10.1113/jphysiol.1974.sp010542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eccles R., Wilson H. The parasympathetic secretory nerves of the nose of the cat. J Physiol. 1973 Apr;230(1):213–223. doi: 10.1113/jphysiol.1973.sp010184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fuhlendorff J., Gether U., Aakerlund L., Langeland-Johansen N., Thøgersen H., Melberg S. G., Olsen U. B., Thastrup O., Schwartz T. W. [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist. Proc Natl Acad Sci U S A. 1990 Jan;87(1):182–186. doi: 10.1073/pnas.87.1.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Herzog H., Hort Y. J., Ball H. J., Hayes G., Shine J., Selbie L. A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5794–5798. doi: 10.1073/pnas.89.13.5794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lacroix J. S. Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa. Acta Physiol Scand Suppl. 1989;581:1–63. [PubMed] [Google Scholar]
  10. Lacroix J. S., Anggård A., Hökfelt T., O'Hare M. M., Fahrenkrug J., Lundberg J. M. Neuropeptide Y: presence in sympathetic and parasympathetic innervation of the nasal mucosa. Cell Tissue Res. 1990 Jan;259(1):119–128. doi: 10.1007/BF00571436. [DOI] [PubMed] [Google Scholar]
  11. Lacroix J. S., Stjärne P., Anggård A., Lundberg J. M. Sympathetic vascular control of the pig nasal mucosa: (I). Increased resistance and capacitance vessel responses upon stimulation with irregular bursts compared to continuous impulses. Acta Physiol Scand. 1988 Jan;132(1):83–90. doi: 10.1111/j.1748-1716.1988.tb08301.x. [DOI] [PubMed] [Google Scholar]
  12. Lundberg J. M., Anggård A., Emson P., Fahrenkrug J., Hökfelt T. Vasoactive intestinal polypeptide and cholinergic mechanisms in cat nasal mucosa: studies on choline acetyltransferase and release of vasoactive intestinal polypeptide. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5255–5259. doi: 10.1073/pnas.78.8.5255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lundberg J. M., Fahrenkrug J., Hökfelt T., Martling C. R., Larsson O., Tatemoto K., Anggård A. Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man. Peptides. 1984 May-Jun;5(3):593–606. doi: 10.1016/0196-9781(84)90090-1. [DOI] [PubMed] [Google Scholar]
  14. Lundberg J. M., Franco-Cereceda A., Hemsén A., Lacroix J. S., Pernow J. Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)-mediated sympathetic cotransmission. Fundam Clin Pharmacol. 1990;4(4):373–391. doi: 10.1111/j.1472-8206.1990.tb00692.x. [DOI] [PubMed] [Google Scholar]
  15. Lundberg J. M., Hemsén A., Larsson O., Rudehill A., Saria A., Fredholm B. B. Neuropeptide Y receptor in pig spleen: binding characteristics, reduction of cyclic AMP formation and calcium antagonist inhibition of vasoconstriction. Eur J Pharmacol. 1988 Jan 5;145(1):21–29. doi: 10.1016/0014-2999(88)90344-5. [DOI] [PubMed] [Google Scholar]
  16. Lundberg J. M., Terenius L., Hökfelt T., Martling C. R., Tatemoto K., Mutt V., Polak J., Bloom S., Goldstein M. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand. 1982 Dec;116(4):477–480. doi: 10.1111/j.1748-1716.1982.tb07171.x. [DOI] [PubMed] [Google Scholar]
  17. Malm L. Stimulation of sympathetic nerve fibres to the nose in cats. Acta Otolaryngol. 1973 Jun;75(6):519–526. doi: 10.3109/00016487309139783. [DOI] [PubMed] [Google Scholar]
  18. Malm L., Sundler F., Uddman R. Effects of vasoactive intestinal polypeptide on resistance and capacitance vessels in the nasal mucosa. Acta Otolaryngol. 1980 Sep-Oct;90(3-4):304–308. doi: 10.3109/00016488009131730. [DOI] [PubMed] [Google Scholar]
  19. Potter E. K. Neuropeptide Y as an autonomic neurotransmitter. Pharmacol Ther. 1988;37(2):251–273. doi: 10.1016/0163-7258(88)90028-9. [DOI] [PubMed] [Google Scholar]
  20. Potter E. K. Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y? Neurosci Lett. 1985 Mar 15;54(2-3):117–121. doi: 10.1016/s0304-3940(85)80065-3. [DOI] [PubMed] [Google Scholar]
  21. Revington M., Potter E. K., McCloskey D. I. Prolonged inhibition of cardiac vagal action following sympathetic stimulation and galanin in anaesthetized cats. J Physiol. 1990 Dec;431:495–503. doi: 10.1113/jphysiol.1990.sp018342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tatemoto K. PHI--a new brain-gut peptide. Peptides. 1984 Mar-Apr;5(2):151–154. doi: 10.1016/0196-9781(84)90198-0. [DOI] [PubMed] [Google Scholar]
  23. Uddman R., Alumets J., Densert O., Håkanson R., Sundler F. Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall. Acta Otolaryngol. 1978 Nov-Dec;86(5-6):443–448. doi: 10.3109/00016487809107524. [DOI] [PubMed] [Google Scholar]
  24. Wahlestedt C., Yanaihara N., Håkanson R. Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept. 1986 Feb;13(3-4):307–318. doi: 10.1016/0167-0115(86)90048-0. [DOI] [PubMed] [Google Scholar]
  25. Widdicombe J. G. The NANC system and airway vasculature. Arch Int Pharmacodyn Ther. 1990 Jan-Feb;303:83–99. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES